FierceBiotech 2026年1月28日 Lilly pens $1.1B pact with German biotech to work on gene editing med for hearing loss
FierceBiotech 2026年1月28日 Medtech M&A 'rebounded' in 2025 as softer valuations drove deal competition: report
FierceBiotech 2026年1月28日 CalciMedica stock craters as calcium channel inhibitor trial stopped over 'safety concern'
FierceBiotech 2026年1月28日 FDA puts clinical hold on Regenxbio gene therapies weeks before approval ruling
FierceBiotech 2026年1月28日 'We have an expansive view:' Kardigan CEO knits sharper trials, digital health into cardio strategy
FierceBiotech 2026年1月27日 Rethinking heart attacks as nervous system gone haywire sparks potential new drug targets
FierceBiotech 2026年1月27日 TD Cowen picks top 3 medtech prospects across its ‘Bones, Bots, and No More Shots’ portfolio
FierceBiotech 2026年1月27日 'AI-native' outpatient surgery startup Oath Surgical inks Nvidia partnership
FierceBiotech 2026年1月27日 United Therapeutics' bioengineered temporary liver shows promise in phase 1 trial
FierceBiotech 2026年1月27日 From gene therapies to … firearms? Italian biotech makes unexpected strategic pivot
FierceBiotech 2026年1月27日 After patient death, FDA lifts hold on 1 of 2 late-stage trials testing Intellia’s CRISPR therapy
FierceBiotech 2026年1月27日 Qilu programs path into cardiometabolic disease with $120M, AI-enabled Insilico alliance
FierceBiotech 2026年1月26日 Ex-CytoDyn CEO sentenced to prison, must pay $5.3M restitution as former CRO leader wins new trial